On Tuesday, Dexcom Inc (NASDAQ: DXCM) was -0.91% drop from the session before settling in for the closing price of $71.35. A 52-week range for DXCM has been $62.34 – $142.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 22.46% over the past five years. When this article was written, the company’s average yearly earnings per share was at 23.15%. With a float of $385.17 million, this company’s outstanding shares have now reached $390.70 million.
Let’s look at the performance matrix of the company that is accounted for 10300 employees. In terms of profitability, gross margin is 60.41%, operating margin of 14.88%, and the pretax margin is 17.58%.
Dexcom Inc (DXCM) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dexcom Inc stocks. The insider ownership of Dexcom Inc is 1.43%, while institutional ownership is 92.81%. The most recent insider transaction that took place on Mar 17 ’25, was worth 24,756. Before that another transaction happened on Mar 12 ’25, when Company’s EVP, Chief Operating Officer sold 14,076 for $70.38, making the entire transaction worth $990,670. This insider now owns 313,497 shares in total.
Dexcom Inc (DXCM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.63% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
You can see what Dexcom Inc (DXCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.85. Likewise, its price to free cash flow for the trailing twelve months is 43.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.42, a number that is poised to hit 0.32 in the next quarter and is forecasted to reach 2.47 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Dexcom Inc (NASDAQ: DXCM) saw its 5-day average volume 3.93 million, a positive change from its year-to-date volume of 3.88 million. As of the previous 9 days, the stock’s Stochastic %D was 17.08%. Additionally, its Average True Range was 2.78.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 11.76%, which indicates a significant increase from 11.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.11% in the past 14 days, which was higher than the 36.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $83.38, while its 200-day Moving Average is $83.34. Nevertheless, the first resistance level for the watch stands at $71.39 in the near term. At $72.09, the stock is likely to face the second major resistance level. The third major resistance level sits at $72.82. If the price goes on to break the first support level at $69.96, it is likely to go to the next support level at $69.23. Assuming the price breaks the second support level, the third support level stands at $68.53.
Dexcom Inc (NASDAQ: DXCM) Key Stats
There are 390,772K outstanding shares of the company, which has a market capitalization of 27.63 billion. As of now, sales total 4,033 M while income totals 576,200 K. Its latest quarter income was 1,114 M while its last quarter net income were 151,700 K.
